Interaction between the mGlu receptors 5 antagonist, MPEP, and amphetamine on memory and motor functions in mice

Psychopharmacology

Volumn 226, Issue 3, 2013, Pages 541-550

  Managò, Francesca ^a   Lopez, Sebastien ^b   Oliverio, Alberto ^a,c   Amalric, Marianne ^b   Mele, Andrea ^a,c   De Leonibus, Elvira ^a,d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b AIX MARSEILLE UNIVERSITY   (France)

^c CNR   (Italy)

^d INSTITUTE OF GENETICS AND BIOPHYSICS ADRIANO BUZZATI TRAVERSO   (Italy)

Author keywords

6 Hydroxydopamine lesion; Amphetamine; Glutamate; Locomotion; Memory consolidation; mGluR5; MPEP; Parkinson's disease; Rotation behavior; Striatum

Indexed keywords

2 METHYL 6 (PHENYLETHYNYL)PYRIDINE; AMPHETAMINE; DOPAMINE; GLUTAMIC ACID;

ADULT ANIMAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG INTERACTION; DRUG MEGADOSE; DRUG POTENTIATION; INFORMATION PROCESSING; LOCOMOTION; LOW DRUG DOSE; MALE; MEMORY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL;

AMPHETAMINE; ANIMALS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MEMORY; MICE; MOTOR ACTIVITY; PYRIDINES; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84876471966     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-012-2925-4     Document Type: Article

References (80)

1. Ambrosi G, Armentero MT, Levandis G, Bramanti P, Nappi G, Blandini F (2010) Effects of early and delayed treatment with an mGluR5 antagonist on motor impairment, nigrostriatal damage and neuroinflammation in a rodent model of Parkinson's disease. Brain Res Bull 82:29-38
2. Anderson JJ, Bradbury MJ, Giracello DR, Chapman DF, Holtz G, Roppe J, King C, Cosford ND, Varney MA (2003) In vivo receptor occupancy of mGlu5 receptor antagonists using the novel radioligand [3H] 3-methoxy-5-(pyridin-2- ylethynyl)pyridine. Eur J Pharmacol 473:35-40
3. Anderson JJ, Rao SP, Rowe B, Giracello DR, Holtz G, Chapman DF, Tehrani L, Bradbury MJ, Cosford ND, Varney MA (2002) [3H]Methoxymethyl-3-[(2-methyl-1, 3-thiazol-4-yl)ethynyl]pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization. J Pharmacol Exp Ther 303:1044-1051
4. Ballard TM, Woolley ML, Prinssen E, Huwyler J, Porter R, Spooren W (2005) The effect of the mGlu5 receptor antagonist MPEP in rodent tests of anxiety and cognition: a comparison. Psychopharmacol (Berl) 179:218-229
5. Barker GR, Bashir ZI, Brown MW, Warburton EC (2006) A temporally distinct role for group I and group II metabotropic glutamate receptors in object recognition memory. Learn Mem 13:178-186
6. Breysse N, Baunez C, Spooren W, Gasparini F, Amalric M (2002) Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism. J Neurosci 22:5669-5678
7. Burket JA, Herndon AL, Winebarger EE, Jacome LF, Deutsch SI (2011) Complex effects of mGluR5 antagonism on sociability and stereotypic behaviors in mice: possible implications for the pharmacotherapy of autism spectrum disorders. Brain Res Bull 86:152-158
8. Campbell UC, Lalwani K, Hernandez L, Kinney GG, Conn PJ, Bristow LJ (2004) The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats. Psychopharmacol (Berl) 175:310-318
9. Car H, Stefaniuk R, Wisniewska RJ (2007) Effect of MPEP in Morris water maze in adult and old rats. Pharmacol Rep 59:88-93
10. Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia - implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272-276
11. Carr DB, Sesack SR (1996) Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopamine terminals. J Comp Neurol 369:1-15
12. Chen G, Greengard P, Yan Z (2004) Potentiation of NMDA receptor currents by dopamine D1 receptors in prefrontal cortex. Proc Natl Acad Sci U S A 101:2596-2600
13. Chen L, Liu J, Ali U, Gui ZH, Hou C, Fan LL, Wang Y, Wang T (2011a) Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist produces anxiolytic-like effects and reverses abnormal firing activity of projection neurons in the basolateral nucleus of the amygdala in rats with bilateral 6-OHDA lesions. Brain Res Bull 84:215-223
14. Chen L, Liu J, Ali U, Gui ZH, Wang Y, Wang T, Hou C, Fan LL (2011b) Blockade of mGluR5 reverses abnormal firing of subthalamic nucleus neurons in 6-hydroxydopamine partially lesioned rats. Chin J Physiol 54:303-309
15. Chen L, Zhang QJ, Liu J, Wang S, Ali U, Gui ZH, Wang Y (2009) Chronic, systemic treatment with a metabotropic glutamate receptor 5 antagonist in 6-hydroxydopamine partially lesioned rats reverses abnormal firing of dopaminergic neurons. Brain Res 1286:192-200
16. Christoffersen GR, Simonyi A, Schachtman TR, Clausen B, Clement D, Bjerre VK, Mark LT, Reinholdt M, Schmith-Rasmussen K, Zink LV (2008) MGlu5 antagonism impairs exploration and memory of spatial and non-spatial stimuli in rats. Behav Brain Res 191:235-245
17. Ciamei A, Cestari V, Castellano C (2000) Strain-dependent interactions between MK-801 and cocaine on retention of C57BL/6 and DBA/2 mice tested in a one-trial inhibitory avoidance task: Involvement of dopaminergic mechanisms. Neurobiol Learn Mem 73:188-194
18. Cleva RM, Olive MF (2011) Positive allosteric modulators of type 5 metabotropic glutamate receptors (mGluR5) and their therapeutic potential for the treatment of CNS disorders. Molecules 16:2097-2106
19. D'Souza MS, Markou A (2011) Metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) microinfusions into the nucleus accumbens shell or ventral tegmental area attenuate the reinforcing effects of nicotine in rats. Neuropharmacol 61:1399-1405
20. De Leonibus E, Lafenetre P, Oliverio A, Mele A (2003) Pharmacological evidence of the role of dorsal striatum in spatial memory consolidation in mice. Behav Neurosci 117:685-694
21. De Leonibus E, Manago F, Giordani F, Petrosino F, Lopez S, Oliverio A, Amalric M, Mele A (2009) Metabotropic glutamate receptors 5 blockade reverses spatial memory deficits in a mouse model of Parkinson's disease. Neuropsychopharmacol 34:729-738
22. De Leonibus E, Mele A, Oliverio A, Pert A (2002) Distinct pattern of c-fos mRNA expression after systemic and intra-accumbens amphetamine and MK-801. Neurosci 115:67-78
23. De Leonibus E, Pascucci T, Lopez S, Oliverio A, Amalric M, Mele A (2007) Spatial deficits in a mouse model of Parkinson disease. Psychopharmacol (Berl) 194:517-525
24. Domenici MR, Potenza RL, Martire A, Coccurello R, Pezzola A, Reggio R, Tebano MT, Popoli P (2005) Chronic treatment with the mGlu5R antagonist MPEP reduces the functional effects of the mGlu5R agonist CHPG in the striatum of 6-hydroxydopamine-lesioned rats: possible relevance to the effects of mGlu5R blockade in Parkinson's disease. J Neurosci Res 80:646-654
25. Ferretti V, Florian C, Costantini VJ, Roullet P, Rinaldi A, De Leonibus E, Oliverio A, Mele A (2005) Co-activation of glutamate and dopamine receptors within the nucleus accumbens is required for spatial memory consolidation in mice. Psychopharmacol (Berl) 179:108-116
26. Gasparini F, Lingenhohl K, Stoehr N, Flor PJ, Heinrich M, Vranesic I, Biollaz M, Allgeier H, Heckendorn R, Urwyler S, Varney MA, Johnson EC, Hess SD, Rao SP, Sacaan AI, Santori EM, Velicelebi G, Kuhn R (1999) 2-Methyl-6- (phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist. Neuropharmacol 38:1493-1503
27. Genkova-Papazova M, Petkova B, Stankova I, Ossowska K, Lazarova-Bakarova M (2007) Effects of MPEP on avoidance learning in rats. Methods Find Exp Clin Pharmacol 29:205-209
28. Halberstadt AL, Lehmann-Masten VD, Geyer MA, Powell SB (2011) Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice. Psychopharmacol (Berl) 215:81-92
29. Herrold AA, Voigt RM, Napier TC (2012) mGluR5 is necessary for maintenance of methamphetamine-induced associative learning. Eur Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2012.05.014
30. Herzig V, Capuani EM, Kovar KA, Schmidt WJ (2005) Effects of MPEP on expression of food-, MDMA-or amphetamine-conditioned place preference in rats. Addict Biol 10:243-249
31. Herzig V, Schmidt WJ (2004) Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Neuropharmacol 47:973-984
32. Homayoun H, Jackson ME, Moghaddam B (2005) Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol 93:1989-2001
33. Homayoun H, Stefani MR, Adams BW, Tamagan GD, Moghaddam B (2004) Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release. Neuropsychopharmacol 29:1259-1269
34. Hsieh MH, Ho SC, Yeh KY, Pawlak CR, Chang HM, Ho YJ, Lai TJ, Wu FY (2012) Blockade of metabotropic glutamate receptors inhibits cognition and neurodegeneration in an MPTP-induced Parkinson's disease rat model. Pharmacol Biochem Behav 102:64-71
35. Jimenez A, Bonastre M, Aguilar E, Marin C (2009) Effect of the metabotropic glutamate antagonist MPEP on striatal expression of the Homer family proteins in levodopa-treated hemiparkinsonian rats. Psychopharmacol (Berl) 206:233-242
36. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507-522
37. Kenny PJ, Boutrel B, Gasparini F, Koob GF, Markou A (2005) Metabotropic glutamate 5 receptor blockade may attenuate cocaine self-administration by decreasing brain reward function in rats. Psychopharmacol (Berl) 179:247-254
38. Klockgether T, Turski L (1990) NMDA antagonists potentiate antiparkinsonian actions of l-dopa in monoamine-depleted rats. Ann Neurol 28:539-546
39. Knopfel T, Kuhn R, Allgeier H (1995) Metabotropic glutamate receptors: novel targets for drug development. J Med Chem 38:1417-1426
40. Konradi C, Leveque JC, Hyman SE (1996) Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium. J Neurosci 16:4231-4239
41. Kroener S, Chandler LJ, Phillips PE, Seamans JK (2009) Dopamine modulates persistent synaptic activity and enhances the signal-to-noise ratio in the prefrontal cortex. PLoS One 4:e6507
42. Kumaresan V, Yuan M, Yee J, Famous KR, Anderson SM, Schmidt HD, Pierce RC (2009) Metabotropic glutamate receptor 5 (mGluR5) antagonists attenuate cocaine priming-and cue-induced reinstatement of cocaine seeking. Behav Brain Res 202:238-244
43. Laruelle M, Kegeles LS, Abi-Dargham A (2003) Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment. Ann N Y Acad Sci 1003:138-158
44. Lee EH, Ma YL (1995) Amphetamine enhances memory retention and facilitates norepinephrine release from the hippocampus in rats. Brain Res Bull 37:411-416
45. Li S, Cullen WK, Anwyl R, Rowan MJ (2003) Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nat Neurosci 6:526-531
46. Maciejak P, Taracha E, Lehner M, Szyndler J, Bidzinski A, Skorzewska A, Wislowska A, Zienowicz M, Plaznik A (2003) Hippocampal mGluR1 and consolidation of contextual fear conditioning. Brain Res Bull 62:39-45
47. Manahan-Vaughan D, Braunewell KH (2005) The metabotropic glutamate receptor, mGluR5, is a key determinant of good and bad spatial learning performance and hippocampal synaptic plasticity. Cereb Cortex 15:1703-1713
48. Manzanedo C, Aguilar MA, Minarro J, Rodriguez-Arias M (2011) Effects of CNQX and MPEP on sensitization to the rewarding effects of morphine. Eur J Pharmacol 654:42-46
49. Marin C, Bonastre M, Aguilar E, Jimenez A (2011) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl) pyridine decreases striatal VGlut2 expression in association with an attenuation of l-DOPA-induced dyskinesias. Synapse 65:1080-1086
50. McGeehan AJ, Janak PH, Olive MF (2004) Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, d-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice. Psychopharmacol (Berl) 174:266-273
51. McGeehan AJ, Olive MF (2003) The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. Synapse 47:240-242
52. Morelli M, Fenu S, Di Chiara G (1992) Blockade of N-methyl-d-aspartate receptors potentiates dopaminergic responses in the 6-OHDA model of Parkinson: differential role of d-1 and d-2 receptors. Neurochem Int 20(Suppl):261S-264S
53. Morin N, Gregoire L, Gomez-Mancilla B, Gasparini F, Di Paolo T (2010) Effect of the metabotropic glutamate receptor type 5 antagonists MPEP and MTEP in parkinsonian monkeys. Neuropharmacol 58:981-986
54. Nandhu MS, Paul J, Kuruvilla KP, Malat A, Romeo C, Paulose CS (2011) Enhanced glutamate, IP3 and cAMP activity in the cerebral cortex of unilateral 6-hydroxydopamine induced Parkinson's rats: effect of 5-HT, GABA and bone marrow cell supplementation. J Biomed Sci 18:5
55. Olds ME (1996) Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801. Eur J Pharmacol 306:23-32
56. Olive MF (2009) Metabotropic glutamate receptor ligands as potential therapeutics for addiction. Curr Drug Abuse Rev 2:83-98
57. Paterson NE, Markou A (2005) The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacol (Berl) 179:255-261
58. Pietraszek M, Rogoz Z, Wolfarth S, Ossowska K (2004) Opposite influence of MPEP, an mGluR5 antagonist, on the locomotor hyperactivity induced by PCP and amphetamine. J Physiol Pharmacol 55:587-593
59. Popik P, Wrobel M (2002) Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacol 43:1210-1217
60. Rodrigues SM, Bauer EP, Farb CR, Schafe GE, LeDoux JE (2002) The group I metabotropic glutamate receptor mGluR5 is required for fear memory formation and long-term potentiation in the lateral amygdala. J Neurosci 22:5219-5229
61. Rutten K, Van Der Kam EL, De Vry J, Bruckmann W, Tzschentke TM (2011) The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats. Addict Biol 16:108-115
62. Rylander D, Iderberg H, Li Q, Dekundy A, Zhang J, Li H, Baishen R, Danysz W, Bezard E, Cenci MA (2010) A mGluR5 antagonist under clinical development improves l-DOPA-induced dyskinesia in parkinsonian rats and monkeys. Neurobiol Dis 39:352-361
63. Sahgal A, Mason J (1985) Drug effects on memory: assessment of a combined active and passive avoidance task. Behav Brain Res 17:251-255
64. Samadi P, Gregoire L, Morissette M, Calon F, Hadj Tahar A, Dridi M, Belanger N, Meltzer LT, Bedard PJ, Di Paolo T (2008) mGluR5 metabotropic glutamate receptors and dyskinesias in MPTP monkeys. Neurobiol Aging 29:1040-1051
65. Schulz B, Fendt M, Gasparini F, Lingenhohl K, Kuhn R, Koch M (2001) The metabotropic glutamate receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) blocks fear conditioning in rats. Neuropharmacol 41:1-7
66. Scott L, Aperia A (2009) Interaction between N-methyl-d-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity. Neurosci 158:62-66
67. Sesack SR, Pickel VM (1990) In the rat medial nucleus accumbens, hippocampal and catecholaminergic terminals converge on spiny neurons and are in opposition to each other. Brain Res 527:266-279
68. Simon NW, Setlow B (2006) Post-training amphetamine administration enhances memory consolidation in appetitive Pavlovian conditioning: implications for drug addiction. Neurobiol Learn Mem 86:305-310
69. Soetens E, Casaer S, D'Hooge R, Hueting JE (1995) Effect of amphetamine on long-term retention of verbal material. Psychopharmacol (Berl) 119:155-162
70. Soetens E, D'Hooge R, Hueting JE (1993) Amphetamine enhances human-memory consolidation. Neurosci Lett 161:9-12
71. Spooren WP, Gasparini F, Bergmann R, Kuhn R (2000a) Effects of the prototypical mGlu(5) receptor antagonist 2-methyl-6-(phenylethynyl)-pyridine on rotarod, locomotor activity and rotational responses in unilateral 6-OHDA-lesioned rats. Eur J Pharmacol 406:403-410
72. Spooren WP, Vassout A, Neijt HC, Kuhn R, Gasparini F, Roux S, Porsolt RD, Gentsch C (2000b) Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents. J Pharmacol Exp Ther 295:1267-1275
73. Steckler T, Oliveira AF, Van Dyck C, Van Craenendonck H, Mateus AM, Langlois X, Lesage AS, Prickaerts J (2005) Metabotropic glutamate receptor 1 blockade impairs acquisition and retention in a spatial water maze task. Behav Brain Res 164:52-60
74. Tokunaga M, Seneca N, Shin RM, Maeda J, Obayashi S, Okauchi T, Nagai Y, Zhang MR, Nakao R, Ito H, Innis RB, Halldin C, Suzuki K, Higuchi M, Suhara T (2009) Neuroimaging and physiological evidence for involvement of glutamatergic transmission in regulation of the striatal dopaminergic system. J Neurosci 29:1887-1896
75. Tronci V, Balfour DJ (2011) The effects of the mGluR5 receptor antagonist 6-methyl-2-(phenylethynyl)-pyridine (MPEP) on the stimulation of dopamine release evoked by nicotine in the rat brain. Behav Brain Res 219:354-357
76. van der Kam EL, de Vry J, Tzschentke TM (2007) Effect of 2-methyl-6-(phenylethynyl) pyridine on intravenous self-administration of ketamine and heroin in the rat. Behav Pharmacol 18:717-724
77. van der Kam EL, De Vry J, Tzschentke TM (2009a) 2-Methyl-6- (phenylethynyl)-pyridine (MPEP) potentiates ketamine and heroin reward as assessed by acquisition, extinction, and reinstatement of conditioned place preference in the rat. Eur J Pharmacol 606:94-101
78. van der Kam EL, De Vry J, Tzschentke TM (2009b) The mGlu5 receptor antagonist 2-methyl-6-(phenylethynyl)pyridine (MPEP) supports intravenous self-administration and induces conditioned place preference in the rat. Eur J Pharmacol 607:114-120
79. Wolf ME, Xue CJ (1999) Amphetamine-induced glutamate efflux in the rat ventral tegmental area is prevented by MK-801, SCH 23390, and ibotenic acid lesions of the prefrontal cortex. J Neurochem 73:1529-1538
80. Yap JJ, Covington HE 3rd, Gale MC, Datta R, Miczek KA (2005) Behavioral sensitization due to social defeat stress in mice: antagonism at mGluR5 and NMDA receptors. Psychopharmacol (Berl) 179:230-239